Preparations are now underway to launch the product through Global Pharmaceuticals, Impax’s generic division.
Adoxa is a tetracycline antibiotic indicated for the treatment of bacterial infections. According to Wolters Kluwer Health, publishers of medical, nursing and allied health information resources, the US sales of Adoxa 150 mg capsules were about $25 million in the year ended December 2010.
Impax also has facilities in Hayward, Philadelphia and Taiwan.